HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks Equity Research
Zacks Rank can tell you which stocks to buy and sell. Zacks Equity Research tells you why. Click here to learn more.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

MIL: Millipore Corp - Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage

MILLIPORE CORP (NYSE)
MIL 67.73 -0.22 (-0.32%) Vol.  656,067 16:02 ET

Day Low - High 67.52 - 67.95
52wk Low - High 43.42 - 72.99
Avg Volume 436,769
Industry INSTRU-SCIENTFC
Market Cap 3.76 B
Div - Yield 0.00 - 0.00
PE (forward) 17.18
PEG Ratio 1.32
Current Year Est. 3.94
EPS Last Year 3.96
Detailed Quote


Premium Research: Stock Analysis

Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
#1 Strong Buy 26.51%
#2 Buy 16.63%
#3 Hold 7.53%
#4 Sell 2.01%
#5 Strong Sell -0.07%
S&P 500 8.70%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


downgraded 11/07/2009
Short-Term Rating 1-3 Months
PREMIUM
Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Outperform, Neutral and Underperform. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations


Long-Term Rating 6+ Months
PREMIUM
Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

PREMIUM
Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

PREMIUM
Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations


Updated as of 11/06/2009
PREMIUM
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium

Premium Research: Industry Analysis

Top Peers Ticker Zacks Rank
MILLIPORE CORP MIL PREMIUM
KEITHLEY INSTR KEI PREMIUM
WATERS CORP WAT PREMIUM
DIONEX CORP DNEX PREMIUM
See all INSTRU-SCIENTFC Peers

BROKERAGE RECOMMENDATIONS
Current ABR 2.20
ABR (Last Week) 2.20
# of Recs in ABR 10
Average Target Price 77.43
Industry Rank by ABR 39 out of 217
Rank in Industry 9 out of 16
More Brokerage Recommendations

Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate MIL?
Buy
Sell
Find out what the Zacks Community
thinks of MIL at PeopleAndPicks.com

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 Comparative Chart



 
ZACKS COMMENTARY FOR MIL
Zacks Blog: Millipore Falls Short of Ests
Nov 06, 2009
Zacks Equity Research: Report for MIL
Nov 06, 2009
Zacks Blog: Millipore & Roka to Collaborate
Sep 16, 2009
Zacks Blog: Zacks #1 Rank Additions for Thursday
Jul 30, 2009
More Zacks Commentary
NEWS
Palladium Names 5 Organizations to Balanced Scorecard Hall of Fame for Executing Strategy
Nov 17, 2009
BiomedReports: News and FDA Updates for Mach One (OTC:MNCN), Millipore (NYSE:MIL), NeoGenomics (OTC:NGNM)
Nov 13, 2009
Millipore Corporation named Corporate Citizen of the Year
Nov 12, 2009
Millipore (MIL) Trading In Tight Support/Resistance Range
Nov 11, 2009
Palladium Balanced Scorecard Hall of Fame for Executing Strategy Inducts Five Performance Leaders at the 2009 Palladium Americas Summit
Nov 11, 2009
More News
EARNINGS ESTIMATES
  This Quarter
12/2009
Next Quarter
03/2010
This Year
12/2009
Next Year
12/2010
Average Estimate 0.94 1.12 3.94 4.42
Number of Estimates 10 4 10 9
Low Estimates 0.90 1.06 3.90 4.30
High Estimate 0.97 1.23 3.97 4.55
Year Ago EPS 0.95 1.06 3.45 3.94
EPS Growth -1.37% 5.19% 14.29% 12.01%

More Estimates

COMPANY DESCRIPTION
Millipore Corporation is a leading provider of products and services that improve productivity and results in biopharmaceutical manufacturing and in clinical, analytical and research laboratories. The Company is organized in two operating divisions. Its Bioprocess Division helps pharmaceutical and biotechnology companies to optimize their manufacturing productivity, ensure the quality of drugs, and scale up the production of difficult-to-manufacture biologics. Its Bioscience Division helps optimize laboratory productivity and workflows by providing reagents, kits and other enabling technologies and products for life science research and development. Millipore has a deep understanding of its customers' research and manufacturing process needs, and offers reliable and innovative tools, technologies and services.

Full Company Report
FINANCIALS
EPS TTM 3.96
Sales 1602.14
Net Income 166.35
Price/Earnings 17.1
Price/Book 2.52
Price/Cash Flow 11.4
Price/Sales 2.31


More Financials

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research